Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above 50-Day Moving Average – Time to Sell?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $276.06 and traded as high as $303.35. Bio-Rad Laboratories shares last traded at $303.15, with a volume of 379 shares changing hands.

Bio-Rad Laboratories Price Performance

The company has a quick ratio of 3.67, a current ratio of 5.12 and a debt-to-equity ratio of 0.17. The firm has a market cap of $8.25 billion, a PE ratio of -12.47 and a beta of 0.81. The firm’s fifty day simple moving average is $276.06 and its two-hundred day simple moving average is $256.78.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $2.26 earnings per share for the quarter. Bio-Rad Laboratories had a negative net margin of 26.43% and a positive return on equity of 4.18%. The business had revenue of $653.00 million for the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.